Atlas Trials

Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID

Clinical trial NCT06597396 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06597396
Sponsor
Beth Israel Deaconess Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Post-COVID ConditionFatigue Symptom
Start date
2024-12-27
Primary completion
2026-03-27
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.